3 juli 2008   Sweden
Protein Sciences shareholders meeting was postponed due to a variety of reasons including that notice of the meeting was not adequate.
The company Emergent BioSolutions has announced a bid on Protein Sciences, a company of which Diamyd Medical owns 6,7% of the shares. The 23rd of June 2008 the proposal was supposed to be put up for approval for the shareholders in Protein Sciences. However, the shareholders meeting was postponed due to a variety of reasons, including that notice of the meeting was not adequate.

Read Bloomberg-article here
Information som presenteras här är inte pressmeddelanden och kan innehålla utdrag ur och länkar till externt publicerat innehåll. Diamyd Medical ansvarar inte för externt publicerat innehåll.

Beställ GAD för preklinisk forskning

GAD-PRODUKTER